JP2003507040A5 - - Google Patents

Download PDF

Info

Publication number
JP2003507040A5
JP2003507040A5 JP2001517682A JP2001517682A JP2003507040A5 JP 2003507040 A5 JP2003507040 A5 JP 2003507040A5 JP 2001517682 A JP2001517682 A JP 2001517682A JP 2001517682 A JP2001517682 A JP 2001517682A JP 2003507040 A5 JP2003507040 A5 JP 2003507040A5
Authority
JP
Japan
Prior art keywords
rotavirus
vaccine composition
antacid
vaccine
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001517682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003507040A (ja
Filing date
Publication date
Priority claimed from GBGB9919468.0A external-priority patent/GB9919468D0/en
Priority claimed from GBGB9927336.9A external-priority patent/GB9927336D0/en
Application filed filed Critical
Priority claimed from PCT/EP2000/007965 external-priority patent/WO2001012797A2/en
Publication of JP2003507040A publication Critical patent/JP2003507040A/ja
Publication of JP2003507040A5 publication Critical patent/JP2003507040A5/ja
Pending legal-status Critical Current

Links

JP2001517682A 1999-08-17 2000-08-15 ワクチン Pending JP2003507040A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9919468.0A GB9919468D0 (en) 1999-08-17 1999-08-17 Vaccine
GB9919468.0 1999-08-17
GB9927336.9 1999-11-18
GBGB9927336.9A GB9927336D0 (en) 1999-11-18 1999-11-18 Vaccine
PCT/EP2000/007965 WO2001012797A2 (en) 1999-08-17 2000-08-15 Method of separating rotavirus variants and live attenuated rotavirus vaccine

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2007211282A Division JP2007319164A (ja) 1999-08-17 2007-08-14 ワクチン
JP2010217093A Division JP5474720B2 (ja) 1999-08-17 2010-09-28 ワクチン

Publications (2)

Publication Number Publication Date
JP2003507040A JP2003507040A (ja) 2003-02-25
JP2003507040A5 true JP2003507040A5 (enExample) 2007-10-04

Family

ID=26315853

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001517682A Pending JP2003507040A (ja) 1999-08-17 2000-08-15 ワクチン
JP2007211282A Withdrawn JP2007319164A (ja) 1999-08-17 2007-08-14 ワクチン
JP2010217093A Expired - Lifetime JP5474720B2 (ja) 1999-08-17 2010-09-28 ワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007211282A Withdrawn JP2007319164A (ja) 1999-08-17 2007-08-14 ワクチン
JP2010217093A Expired - Lifetime JP5474720B2 (ja) 1999-08-17 2010-09-28 ワクチン

Country Status (42)

Country Link
US (4) US7285280B1 (enExample)
EP (1) EP1212084B1 (enExample)
JP (3) JP2003507040A (enExample)
KR (1) KR100695599B1 (enExample)
CN (1) CN100379451C (enExample)
AP (1) AP1768A (enExample)
AR (1) AR029643A1 (enExample)
AT (1) ATE327765T1 (enExample)
AU (1) AU767885B2 (enExample)
BG (1) BG65314B1 (enExample)
BR (1) BRPI0013357B8 (enExample)
CA (1) CA2379196C (enExample)
CO (1) CO5580165A1 (enExample)
CY (2) CY1106103T1 (enExample)
CZ (1) CZ302173B6 (enExample)
DE (2) DE60028390T2 (enExample)
DK (1) DK1212084T3 (enExample)
DZ (1) DZ3219A1 (enExample)
EA (1) EA005952B1 (enExample)
ES (1) ES2260046T3 (enExample)
FR (1) FR06C0018I2 (enExample)
HK (1) HK1046860B (enExample)
HU (2) HU228975B1 (enExample)
IL (3) IL147926A0 (enExample)
LU (1) LU91251I2 (enExample)
MA (1) MA25489A1 (enExample)
MX (1) MXPA02001648A (enExample)
MY (1) MY133158A (enExample)
NL (1) NL300233I2 (enExample)
NO (2) NO328112B1 (enExample)
NZ (1) NZ517131A (enExample)
OA (1) OA12312A (enExample)
PE (1) PE20010487A1 (enExample)
PL (1) PL205550B1 (enExample)
PT (1) PT1212084E (enExample)
SI (1) SI1212084T1 (enExample)
SK (1) SK287261B6 (enExample)
TR (1) TR200200420T2 (enExample)
TW (1) TWI283270B (enExample)
UA (1) UA77388C2 (enExample)
UY (1) UY26297A1 (enExample)
WO (1) WO2001012797A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY133158A (en) * 1999-08-17 2007-10-31 Smithkline Beecham Biologicals S A Vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
KR20030026654A (ko) * 2001-09-26 2003-04-03 주식회사 씨트리 인간 로타바이러스의 활성을 저해하는 항체의 생산용 항원및 그의 제조방법과 이용
KR20060126917A (ko) * 2003-09-02 2006-12-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0414787D0 (en) 2004-07-01 2004-08-04 Glaxosmithkline Biolog Sa Method
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
WO2007020078A2 (en) * 2005-08-17 2007-02-22 Glaxosmithkline Biologicals S.A. Rotavirus vaccine inducing heterotypic cross protection
CA2630220C (en) 2005-11-22 2020-10-13 Doris Coit Norovirus and sapovirus antigens
KR101051986B1 (ko) * 2006-09-28 2011-07-26 중앙대학교 산학협력단 인간로타바이러스 및 이를 이용한 백신 조성물
EP2099485B1 (en) 2006-11-03 2018-03-21 AlphaVax, Inc. Alphavirus and alphavirus replicon particle formulations and methods
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
CA3121654A1 (en) 2009-05-12 2010-11-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention New human rotavirus strains and vaccines
MY162326A (en) * 2009-07-13 2017-05-31 Bharat Biotech Int Ltd A composition useful as rotavirus vaccine and a method therefor
FR2960781B1 (fr) * 2010-06-07 2013-11-22 Sanofi Pasteur Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
JP6126684B2 (ja) 2012-04-23 2017-05-10 バハラ バイオテック インターナショナル リミテッド 新規なロタウイルスワクチン組成物及び同組成物を調製する方法
NZ631348A (en) 2012-08-27 2017-02-24 Murdoch Childrens Res Inst Modified human rotaviruses and uses therefor
RS62664B1 (sr) * 2015-05-21 2021-12-31 Univ Xiamen Okrnjen vp4 protein rotavirusa i njegova primena
WO2017062246A1 (en) 2015-10-05 2017-04-13 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human rota virus g9p[6] strain and use as a vaccine
US11413346B2 (en) * 2015-11-09 2022-08-16 Curevac Ag Rotavirus vaccines
RU2018126322A (ru) * 2015-12-18 2020-01-20 Мерк Шарп И Доум Корп. Термически стабильные ротавирусные вакцинные композиции и способы их применения
MA44557B1 (fr) 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
GB201614799D0 (en) 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
CN110856493B (zh) * 2018-08-20 2022-02-25 中国烟草总公司黑龙江省公司牡丹江烟草科学研究所 一种植物病毒弱毒疫苗组合物、弱毒疫苗保存方法及其应用
WO2024242174A1 (ja) * 2023-05-24 2024-11-28 国立大学法人大阪大学 一回感染性ロタウイルスおよびその利用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927323B2 (ja) 1976-10-12 1984-07-05 花王株式会社 歯みがき組成物
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4571385A (en) 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4624850A (en) 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
ES2121841T3 (es) 1990-11-16 1998-12-16 Childrens Hosp Medical Center Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.
US5471385A (en) * 1992-05-21 1995-11-28 Tsubakimoto Chain Co. Routeless guiding method for moving body
US5773009A (en) 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
US7150984B2 (en) 1994-07-11 2006-12-19 The United States Of America As Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
US5932223A (en) 1996-09-26 1999-08-03 Merck & Co., Inc. Rotavirus vaccine formulations
AU739916B2 (en) * 1996-09-26 2001-10-25 Merck Sharp & Dohme Corp. Rotavirus vaccine formulations
US6403098B1 (en) 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
MY133158A (en) * 1999-08-17 2007-10-31 Smithkline Beecham Biologicals S A Vaccine

Similar Documents

Publication Publication Date Title
JP2003507040A5 (enExample)
JP5474720B2 (ja) ワクチン
JP2002536293A (ja) ロタウィルスサブユットワクチン
JP5588586B2 (ja) ワクチン
JP5519934B2 (ja) 異型交差防御を誘導するロタウイルスワクチン
ES2566394T3 (es) Vacuna de rotavirus
ES2339043T3 (es) Procedimiento para separar variantes de rotavirus y vacuna de rotavirus atenuado vivo.
CN100448485C (zh) 疫苗
CN101291690A (zh) 诱导异型交叉保护的轮状病毒疫苗